How Much Did Biofourmis Raise? Headquarters, Funding & Key Investors

Biofourmis, founded in 2015 and headquartered in Boston, Massachusetts, has raised a total of $463.6 million across nine funding rounds, reaching a valuation of at least $1 billion as of April 2022. The company’s funding journey includes a $35 million Series B in 2019, a $100 million Series C led by SoftBank Vision Fund in 2020, and a $300 million Series D led by General Atlantic in April 2022, followed by a $20 million extension from Intel Capital in July 2022. Biofourmis uses AI-driven health analytics and digital therapeutics to power virtual care globally.

How Much Did Biofourmis Raise? Funding & Key Investors

Biofourmis is a Boston-based digital health and biotechnology company specializing in virtual care and remote patient monitoring solutions. Since its founding in 2015, the company has raised $463.6 million from top investors, including General Atlantic, SoftBank Vision Fund, and Intel Capital. It has achieved a current valuation of at least $1 billion. Biofourmis leverages AI-driven predictive analytics and digital therapeutics to help hospitals, health systems, and payers deliver personalized, outcomes-focused care while optimizing clinical workflows and operational efficiency.

What Is Biofourmis and What Does It Do?

Biofourmis, founded in 2015 by Kuldeep Singh Rajput, Maulik Majmudar, and Wendou Niu, is headquartered in Boston, Massachusetts. The company provides a cloud-based suite of virtual care and patient monitoring solutions for healthcare organizations, including its flagship platform Biovitals, which supports patient engagement, communication, and remote health tracking.

With a team of 190 employees, Biofourmis partners with hospitals, health systems, and payers to improve care coordination, optimize clinical workflows, and enhance patient outcomes. Its technology integrates with electronic health records and supports digital therapeutics, enabling personalized care and predictive health monitoring.

How Much Funding Has Biofourmis Raised?

1. Angel Round

Amount Raised: SGD 100K
Date: December 2015
Motivation: Initial funding to kickstart operations and develop early-stage technology.

2. Angel Round

Amount Raised: $1M
Date: August 2016
Lead Investors: Eden Strategy Institute, SpesNet Pte. Ltd.
Motivation: To expand the team and accelerate product development.

3. Seed Round

Amount Raised: $500K
Date: May 2017
Lead Investors: SpesNet Pte. Ltd.
Motivation: To further develop the technology platform and prepare for market entry.

4. Series A

Amount Raised: $5M
Date: December 2017
Lead Investors: Aviva Ventures, Openspace
Motivation: To scale operations and enhance product offerings.

5. Series A

Amount Raised: $2M
Date: May 2018
Motivation: To continue scaling and improving the technology platform.

6. Series B

Amount Raised: $35M
Date: May 2019
Lead Investors: MMV Europe & Asia-Pacific, Peak XV Partners
Motivation: To expand market reach and enhance product capabilities.

7. Series C

Amount Raised: $100M
Date: September 2020
Lead Investors: SoftBank Vision Fund
Motivation: To accelerate global expansion and product development.

8. Series D

Amount Raised: $300M
Date: April 2022
Lead Investors: General Atlantic
Motivation: To support growth and expansion in the healthtech sector.

9. Series D

Amount Raised: $20M
Date: July 2022
Lead Investors: Intel Capital
Motivation: To further support growth and technological advancements.

Total Funding Raised: $463.6 Million

Current Valuation: $1 Billion (as of April 2022)

Latest Funding Date: July 2022

Key Investors

1. Intel Capital

Details: Investment arm of Intel Corporation, focusing on innovative technology companies.
Investment Focus Areas: Artificial intelligence, autonomous driving, data center, cloud, healthtech.
Notable Investments: Cloudera, DocuSign, Vuzix.

2. CVS Health

Details: Healthcare innovation company operating pharmacies and clinics across the U.S.
Investment Focus Areas: Healthcare innovation, digital health, patient care solutions.
Notable Investments: Aetna, Omnicare, Coram.

3. SoftBank Vision Fund

Details: One of the most significant technology-focused investment funds in the world.
Investment Focus Areas: Artificial intelligence, robotics, telecommunications, e-commerce.
Notable Investments: Uber, WeWork, Arm Holdings.

4. General Atlantic

Details: Global growth equity firm providing capital and strategic support for growth companies.
Investment Focus Areas: Technology, healthcare, financial services, and consumer.
Notable Investments: Airbnb, Slack, Uber.

Where Is Biofourmis’ Headquarters?

Biofourmis is headquartered in Boston, Massachusetts, providing access to a leading healthcare ecosystem, top medical talent, and strategic partnerships with hospitals and research institutions.

What’s Next for Biofourmis?

Biofourmis is positioned for significant growth in the digital health and remote patient monitoring space. Leveraging its recent $20M funding from Intel Capital and previous $300M Series D round, the company aims to scale operations, expand its platform globally, and further integrate predictive analytics for personalized care. Future initiatives include broadening hospital partnerships, enhancing clinical workflow solutions, and exploring potential strategic acquisitions to solidify its leadership in healthtech.

Get Investor & Funding Insights with TexAu

TexAu helps sales and business teams uncover detailed fundraising information on companies like Biofourmis. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.